Stock listing
0SGC Stock Price, News, Filings & Events — Arbutus Biopharma Corporation
Selected listing: 0SGC · LSE · USD · GB
This page tracks Arbutus Biopharma Corporation's 0SGC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0SGC:LSE. 0SGC:LSE is the stock-level entry point for investors researching Arbutus Biopharma Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 0SGC:LSE
- Asset type
- Stock
- Market cap
- $992.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Arbutus Biopharma Corporation 0SGC:LSE stock context
This page tracks Arbutus Biopharma Corporation's 0SGC:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0SGC:LSE. 0SGC:LSE is the stock-level entry point for investors researching Arbutus Biopharma Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Arbutus Biopharma Corporation
Arbutus Biopharma : Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
August 24, 2026
Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share
August 24, 2026
Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer
August 21, 2026
Arbutus Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
July 16, 2026
Arbutus Biopharma Corporation earnings calls
Arbutus Biopharma Corporation (ABUS) Q3 2024 Earnings Call
November 6, 2024 · Replay with transcript and chapters
Arbutus Biopharma Corporation (ABUS) Q2 2024 Earnings Call
August 1, 2024 · Replay with transcript and chapters
Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call
May 2, 2024 · Replay with transcript and chapters
Arbutus Biopharma Corporation (ABUS) Q4 2023 Earnings Call
February 29, 2024 · Replay with transcript and chapters
Arbutus Biopharma Corporation (ABUS) Q3 2023 Earnings Call
November 7, 2023 · Replay with transcript and chapters
Arbutus Biopharma Corporation (ABUS) Q2 2023 Earnings Call
August 3, 2023 · Replay with transcript and chapters
Research Arbutus Biopharma Corporation
Arbutus Biopharma Corporation investor report
Review AI stock analysis and investor report context for 0SGC:LSE.
Arbutus Biopharma Corporation company profile
View the public company page for Arbutus Biopharma Corporation on 6ix.
Arbutus Biopharma Corporation news
Read company news and market updates connected to Arbutus Biopharma Corporation.
Arbutus Biopharma Corporation investor events
Find investor webinars, events, and replay context for Arbutus Biopharma Corporation.
Alternate listings
ABUS:NASDAQ
US · USD
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
A14XMD:LSX
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
A14XMD:LS
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
ABUS:BOATS
US · USD
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:GETTEX
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:SWB
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:DUS
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:FWB
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:MUN
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.
I9DN:TRADEGATE
DE · EUR
Alternate listing for Arbutus Biopharma Corporation; the primary context on this page is 0SGC:LSE.